CLINICAL PHARMACOKINETICS OF KETOPROFEN AFTER SINGLE INTRAVENOUS ADMINISTRATION AS A BOLUS OR INFUSION

被引：36

作者：

DEBRUYNE, D ^{[1
]}

DELIGNY, BH ^{[1
]}

RYCKELYNCK, JP ^{[1
]}

ALBESSARD, F ^{[1
]}

MOULIN, M ^{[1
]}

机构：

[1] UNIV CAEN,CHR,DIV NEPHROL,F-14033 CAEN,FRANCE

来源：

CLINICAL PHARMACOKINETICS | 1987年 / 12卷 / 03期

关键词：

D O I：

10.2165/00003088-198712030-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：214 / 221

页数：8

共 26 条

[11] URINARY PHARMACOKINETICS OF ORALLY-ADMINISTERED KETOPROFEN IN MAN [J].

HOUGHTON, GW ;

DENNIS, MJ ;

RIGLER, ED ;

PARSONS, RL .

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (03) :201-204

[12] COMPARATIVE PHARMACOKINETICS OF KETOPROFEN DERIVED FROM SINGLE ORAL DOSES OF KETOPROFEN CAPSULES OR A NOVEL SUSTAINED-RELEASE PELLET FORMULATION [J].

HOUGHTON, GW ;

DENNIS, MJ ;

RIGLER, ED ;

PARSONS, RL .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (03) :203-209

[13]

HOWARD DLG, 1978, CURR THER RES CLIN E, V23, P678

[14] PHARMACOKINETICS OF KETOPROFEN FOLLOWING SINGLE ORAL, INTRAMUSCULAR AND RECTAL DOSES AND AFTER REPEATED ORAL-ADMINISTRATION [J].

ISHIZAKI, T ;

SASAKI, T ;

SUGANUMA, T ;

HORAI, Y ;

CHIBA, K ;

WATANABE, M ;

ASUKE, W ;

HOSHI, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (05) :407-414

[15]

JACQOUT C, 1978, PHARMACOL CLIN, V1, P35

[16]

KUBOTA T, 1979, ARCH INT PHARMACOD T, V237, P169

[17]

LEWELLEN ORW, 1976, SCAND J RHEUMATOL, V14, P53

[18]

LUNDSTAM SOA, 1982, LANCET, V1, P1096

[19]

OLSEN UB, 1976, ACTA PHYSL SCAND, V97, P364

[20]

SERRATRICE G, 1980, 1979 S KET WIESB, P51

← 1 2 3 →